Ecalmpsia: maternal and fetal outcome

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Public Health

Background:

• Eclampsia is a severe complication of pregnancy characterized by seizures.
• High rates of maternal and fetal morbidity and mortality are associated with eclampsia.
• Antenatal care and appropriate management of hypertensive disorders in pregnancy are crucial.

Purpose of the Study:

• To determine the incidence of eclampsia.
• To examine maternal and fetal outcomes in eclampsia cases.
• To evaluate the effectiveness of different anticonvulsant medications.

Main Methods:

• Prospective analysis of 120 consecutive eclampsia admissions.
• Data collection on maternal and fetal morbidity and mortality.
• Comparison of outcomes based on anticonvulsant use (diazepam vs. magnesium sulphate).

Main Results:

• Eclampsia incidence was 1.2% of deliveries.
• Maternal complication rate was 39.2%, associated with diazepam use.
• Stillbirth rate was 22.5%, also associated with diazepam use.
• Case fatality rate was 11.7%; diazepam use showed no significant association with maternal death.

Conclusions:

• High incidence of eclampsia and associated poor maternal-fetal outcomes were observed.
• Increased antenatal screening is vital for early detection and prevention.
• Magnesium sulphate is recommended for convulsion control to reduce morbidity and mortality.